Communications Biology (Mar 2021)

Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A

  • Suzan Boutary,
  • Marie Caillaud,
  • Mévidette El Madani,
  • Jean-Michel Vallat,
  • Julien Loisel-Duwattez,
  • Alice Rouyer,
  • Laurence Richard,
  • Céline Gracia,
  • Giorgia Urbinati,
  • Didier Desmaële,
  • Andoni Echaniz-Laguna,
  • David Adams,
  • Patrick Couvreur,
  • Michael Schumacher,
  • Charbel Massaad,
  • Liliane Massaad-Massade

DOI
https://doi.org/10.1038/s42003-021-01839-2
Journal volume & issue
Vol. 4, no. 1
pp. 1 – 14

Abstract

Read online

Boutary et al. describe siRNA based therapy conjugated with squalene nanoparticles as an efficient approach to normalize PMP22 protein levels, restore locomotor activity, electrophysiological parameters and function of myelin sheath in CMT1A mouse models. These findings could be useful to develop therapeutic strategies for inherited peripheral neuropathies.